Need immediate assistance? Call 1-518-730-0559 (Us-Canada Toll Free) or Contact Us


Atrophic Scar Treatment Market to Grow at 4.6% CAGR through 2025

Press release Description

Albany, New York, June 18, 2018: A new detailed study titled “Global Market Study on Atrophic Scar Treatment: Close Fight Between APAC and Europe Markets in Terms of both Revenue Share and Growth Rate” has recently been submitted to the repository of Market Research Reports Search Engine (MRRSE). According to the study, the atrophic scar treatment market is likely to grow at 4.6% CAGR during the assessment period.

The business intelligence study offers in-depth analysis and insights on the atrophic scar treatment market. According to the study, increase in the prevalence of skin disorders, combined with availability of novel treatment solutions has led to the growth of the market. Increase in the health expenditure by both governments and private organizations is leading to further growth of the market.

Geographically, the market is divided into key regions globally which are North America, Latin America, Europe, Asia Pacific Excluding Japan, Middle East & Africa and Japan. According to the study, North America is likely to remain one of the leading markets for atrophic scar treatment market. The demand for these products and solutions in North America is likely to remain concentrated in the US, whereas market is likely to grow at a significant pace in Canada as well.

Asia Pacific excluding Japan (APEJ) is likely to maintain its position as one of the leading markets for atrophic scar treatment. The market in APEJ continues to be driven by rising disposable income among the middle class in some of the fastest growing economies around the globe. China and India are among the lucrative markets for atrophic scar treatment, and it is likely that leading manufacturers will bolster their presence in these two countries during the course of the forecast period.

In addition to North America and Asia Pacific, Latin America is likely to emerge as an attractive market for atrophic scar treatment market. The growing awareness among consumers in Latin America is expected to provide a fillip to market growth during the assessment period.

The report profiles some of the leading players operating in the market. The business and product strategies of some of the leading players in the market has been discussed in detail in the report. Some of the key players operating in atrophic scar treatment market include Cynosure, Inc., Avita Medical Limited, Smith & Nephew Inc., Merz inc., CCA Industries Inc., Occulus Innovative Sciences, Inc., Pacific World Corp., Molnlycke Health Care, Valeant Inc., Shanghai Fosun Pharmaceuticals (Alma Lasers), Enaltus LLC, Sonoma Pharmaceuticals, Inc., and LUMENIS.

Browse Full Global Atrophic Scar Treatment Market Report with TOC :

Market Research Reports Search Engine (MRRSE) is an industry-leading database of market intelligence reports. MRRSE is driven by a stellar team of research experts and advisors trained to offer objective advice. Our sophisticated search algorithm returns results based on the report title, geographical region, publisher, or other keywords.

MRRSE partners exclusively with leading global publishers to provide clients single-point access to top-of-the-line market research. MRRSE’s repository is updated every day to keep its clients ahead of the next new trend in market research, be it competitive intelligence, product or service trends or strategic consulting.


State Tower
90, State Street
Suite 700
Albany, NY – 12207
United States

Telephone: +1-518-730-0559